Showing results (61-70 of 148) with videos related to
Sort By:
Pageof 15
Journal of Medical Virology|June 2, 2004
Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipientsDaniele Lilleri, Fausto Baldanti, Marta Gatti, et al.Journal of Medical Virology|September 20, 2023
Correlates of postnatal human cytomegalovirus transmission in term babies in the first yearPiera d'Angelo, Paola Zelini, Federica Zavaglio, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 24, 2019
Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancyPaola Zelini, Chiara Fornara, Milena Furione, et al.Plos One|August 1, 2012
Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantationDaniele Lilleri, Giuseppe Gerna, Paola Zelini, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infectionLaura Gibson, Giampiero Piccinini, Daniele Lilleri, et al.Clinical Immunology (Orlando, Fla.)|May 25, 2010
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised hostPaola Zelini, Daniele Lilleri, Giuditta Comolli, et al.Frontiers in Medicine|November 17, 2022
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatmentAngioletta Lasagna, Irene Cassaniti, Daniele Lilleri, et al.Microorganisms|July 27, 2024
Evaluation of the In Vitro Capacity of Anti-Human Cytomegalovirus Antibodies to Initiate Antibody-Dependent Cell CytotoxicityPiera d'Angelo, Federica Zavaglio, Elisa Gabanti, et al.Journal of Medical Virology|January 19, 2006
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipientsGiuseppe Gerna, Patrizio Vitulo, Francesca Rovida, et al.The Journal of General Virology|May 23, 2001
In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cellsM Grazia Revello, Fausto Baldanti, Elena Percivalle, et al.Pageof 15